Tokyo, Oct. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059253) titled 'Optimising radioiodine therapy strategies for thyroid cancer in Japan' on Oct. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka University Hospital
Condition:
Condition - Thyroid cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Establishment of treatment dose and interval aimed at safety and long-term improvement of prognosis
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with thyroid cancer who underwent total thyroidectomy and required radioiodine therapy
Key exclusion criteria - Patients with unknown medical history
Target Size - 400
Recruitment Status:
Recruitment status - Main results already published
Date of protocol fixation - 2019 Year 05 Month 13 Day
Date of IRB - 2019 Year 05 Month 13 Day
Anticipated trial start date - 2019 Year 07 Month 01 Day
Last follow-up date - 2027 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067773
Disclaimer: Curated by HT Syndication.
